Evaluation of propofol sparing effect of intravenous lignocaine in patients undergoing daycare upper Gastro Intestinal endoscopic procedures

Not yet recruiting

Conditions: Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere, (2) ICD-10 Condition: O||Medical and Surgical, (3) ICD-10 Condition: K831||Obstruction of bile duct,

Registration Number: CTRI/2020/10/028697

Lead Sponsor: Indira Gandhi Institute of Medical Sciences

Brief Summary: Sedation protocol employed during endoscopic procedures might hinder early recovery and discharge from hospital.We intend to observe whether addition of lignocaine to sedation protocol help early discharge from hospital.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 90

Inclusion Criteria

Patients of age 18-65 years ASA Grade-I & II Undergoing day care upper G.I. endoscopic procedures under sedation.

Exclusion Criteria

Patient refusal ASA Grade-III & IV Unstable hemodynamic status Mental disorders, such as schizophrenia and psychosis on long-term psychotropic drugs Hyperalgesia or refractory cancer pain Allergic to study agent.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Total amount of propofol administered during the procedure	After procedure
2.Total supplemental amount of propofol after induction and	After procedure
3.Number of boluses of supplemental propofol	After procedure

Secondary Outcome Measures

Name	Time	Method
Recovery scores	VAS score

Trial Locations

Locations (1): Indira Gandhi Institute of Medical Sciences
🇮🇳
Patna, BIHAR, India
Indira Gandhi Institute of Medical Sciences
🇮🇳Patna, BIHAR, India
Mumtaz Hussain
Principal investigator
9973152076
drhussain72@yahoo.co.in